EXECUTIVE ENGAGEMENTS
POOL
1852
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
333
Interactions with Platform & by Email
PARTICIPANTS
74
Unique # Participated
VALIDATIONS
17
Responses Validated*
COMPANIES
37
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
122
PAGES
193
EDITION
18
PRICE
USD 5450
CODE
MCP-6829
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for ePharmacies estimated at US$56.9 Billion in the year 2020, is projected to reach a revised size of US$169.6 Billion by 2027, growing at aCAGR of 16.9% over the period 2020-2027. Over-the-Counter Products, one of the segments analyzed in the report, is projected to record 16.5% CAGR and reach US$110.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prescription Medicine segment is readjusted to a revised 17.6% CAGR for the next 7-year period.
The ePharmacies market in the U.S. is estimated at US$16.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.4 Billion by the year 2027 trailing a CAGR of 16.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15% and 14.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.4% CAGR.
SELECT PLAYERS
1mg Technologies Pvt. Ltd.; Canada Drugs; DocMorris NV; Dr Fox Pharmacy; eDrugstore.com; Express Scripts Holding Company; Giant Eagle, Inc.; InternationalDrugMart.com; MediSave; Netmeds Marketplace Limited; OptumRx, Inc.; PlanetRx; Rowlands Pharmacy; The Kroger Company; Walgreen Co., ; Wal-Mart Stores, Inc.; Zur Rose Group AG
SEGMENTS
» Product Segment (Over-the-Counter Products, Prescription Medicine)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| ePharmacy on the Roll Despite Stumbling Blocks |
| Recent Market Activity |
| Inherent Benefits of the Channel - A Key Driving Factor |
| Regulations - A Game Changer for the ePharmacy Market |
| Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 1mg Technologies Pvt. Ltd. (India) |
| Canada Drugs (Canada) |
| Dr Fox Pharmacy (UK) |
| eDrugstore.com (USA) |
| Express Scripts Holding Company (USA) |
| Giant Eagle, Inc. (USA) |
| InternationalDrugMart.com (Cyprus) |
| Lloyds Pharmacy Ltd. (UK) |
| MediSave (Canada) |
| Netmeds Marketplace Limited (India) |
| OptumRx, Inc. (USA) |
| PlanetRx (UK) |
| Rowlands Pharmacy (UK) |
| Sanicare-Apotheke (Germany) |
| T.mall.com (China) |
| The Kroger Company (USA) |
| Walgreen Co. (USA) |
| Wal-Mart Stores, Inc. (USA) |
| Yihaodian (China) |
| Zur Rose Group AG (Switzerland) |
| DocMorris NV (Netherlands) |
| 3. MARKET TRENDS & DRIVERS |
| ePharmacies Bring Potential Value to Customers |
| ePharmacies Enable Better Care and Enhance Quality of Life |
| Prescription Drugs Fuel the Growth of Electronic Pharmacies |
| Increasing Healthcare Spending in Emerging Markets: Opportunities in Store |
| Ballooning Elderly Population: The Vital Growth Driver |
| Internet Globalizes Drug Sales through ePharmacies |
| Expanding Internet User Base: A Key Driving Force |
| Rising Smartphone Usage Supports Growing Adoption |
| Re-importation or Cross Border Drug Sales: An Area of Concern in the US |
| Cyber Crime in the Name of ePharmacies on the Rise |
| Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs |
| Perils of Counterfeit and Fake Drugs |
| Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 37 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com